Market overview
The global retail clinic market is worth USD 6.3 bn in 2026 and is forecast to reach USD 10.6 bn by 2036, growing at a 5.3% CAGR. United States is the largest country market and Acute minor illness is the largest by service segment.
| Scope | Walk-in clinics located in pharmacies, supermarkets and big-box retailers that treat minor illnesses, give vaccinations and run screenings, measured by clinic service revenue. |
|---|---|
| Industry | Healthcare |
| Value 2025 | USD 6.0 bn |
| Value 2026 | USD 6.3 bn |
| Value 2036 | USD 10.6 bn |
| CAGR 2026-2036 | 5.3% |
| Volume 2026 | 61.5 million visits |
| Volume 2036 | 80.5 million visits |
| Average price 2026 | USD 102 per visit |
| Report price | Starts from USD 1,999 |
| Published | November 2026 |
Request a free sample of this report
Retail Clinic market size and forecast, 2026-2036
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Year | Market value |
|---|---|
| 2026 | USD 6.3 bn |
| 2027 | USD 6.6 bn |
| 2028 | USD 7.0 bn |
| 2029 | USD 7.4 bn |
| 2030 | USD 7.7 bn |
| 2031 | USD 8.2 bn |
| 2032 | USD 8.6 bn |
| 2033 | USD 9.0 bn |
| 2034 | USD 9.5 bn |
| 2035 | USD 10.0 bn |
| 2036 | USD 10.6 bn |
Retail Clinic market segmentation
By service
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Acute minor illness | 42.0% | 34.5% | USD 2.6 bn | 3.3% |
| Vaccinations | 24.0% | 22.8% | USD 1.5 bn | 4.8% |
| Screening and wellness | 18.0% | 21.6% | USD 1.1 bn | 7.2% |
| Chronic care management | 16.0% | 21.1% | USD 1.0 bn | 8.2% |
By operator type
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Pharmacy chains | 72.0% | 70.0% | USD 4.5 bn | 5.0% |
| Grocery and mass retailers | 20.0% | 21.4% | USD 1.3 bn | 6.0% |
| Other | 8.0% | 8.6% | USD 504 mn | 6.0% |
By location
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Inside pharmacy | 46.0% | 44.0% | USD 2.9 bn | 4.8% |
| Inside grocery or mass retailer | 34.0% | 32.0% | USD 2.1 bn | 4.7% |
| Standalone mall or street | 20.0% | 24.0% | USD 1.3 bn | 7.2% |
By payer
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Commercial insurance | 52.0% | 50.0% | USD 3.3 bn | 4.9% |
| Medicare and Medicaid | 22.0% | 24.0% | USD 1.4 bn | 6.2% |
| Self-pay | 26.0% | 26.0% | USD 1.6 bn | 5.3% |
By staffing
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Nurse practitioner | 68.0% | 62.0% | USD 4.3 bn | 4.3% |
| Physician assistant | 20.0% | 22.0% | USD 1.3 bn | 6.3% |
| Telehealth-supported | 12.0% | 16.0% | USD 756 mn | 8.4% |
Top 25 countries for retail clinic by revenue
Countries are ranked by revenue earned from sales in the country, not by where the product is made. The ten largest hold 99.4% of 2026 revenue and the 25 countries below together hold 99.8%.
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| # | Country | Value 2026 | Share 2026 | Value 2036 | CAGR 2026-36 |
|---|---|---|---|---|---|
| 1 | United States | USD 5.4 bn | 86.0% | USD 8.9 bn | 5.1% |
| 2 | United Kingdom | USD 252 mn | 4.0% | USD 454 mn | 6.1% |
| 3 | Canada | USD 189 mn | 3.0% | USD 359 mn | 6.6% |
| 4 | Australia | USD 126 mn | 2.0% | USD 243 mn | 6.8% |
| 5 | Netherlands | USD 63 mn | 1.0% | USD 116 mn | 6.3% |
| 6 | Japan | USD 63 mn | 1.0% | USD 106 mn | 5.3% |
| 7 | Germany | USD 50 mn | 0.8% | USD 95 mn | 6.5% |
| 8 | France | USD 38 mn | 0.6% | USD 63 mn | 5.3% |
| 9 | Spain | USD 32 mn | 0.5% | USD 53 mn | 5.3% |
| 10 | Brazil | USD 32 mn | 0.5% | USD 74 mn | 8.9% |
| 11 | Italy | USD 5.7 mn | 0.09% | USD 8.4 mn | 4.1% |
| 12 | Mexico | USD 3.8 mn | 0.06% | USD 7.4 mn | 6.9% |
| 13 | Saudi Arabia | USD 2.5 mn | 0.04% | USD 5.3 mn | 7.7% |
| 14 | India | USD 1.9 mn | 0.03% | USD 4.2 mn | 8.4% |
| 15 | Sweden | USD 1.9 mn | 0.03% | USD 2.1 mn | 1.1% |
| 16 | South Korea | USD 1.3 mn | 0.02% | USD 2.1 mn | 5.3% |
| 17 | Singapore | USD 1.3 mn | 0.02% | USD 3.2 mn | 9.7% |
| 18 | Poland | USD 1.3 mn | 0.02% | USD 2.1 mn | 5.3% |
| 19 | South Africa | USD 1.3 mn | 0.02% | USD 2.1 mn | 5.3% |
| 20 | Turkey | USD 1.3 mn | 0.02% | USD 2.1 mn | 5.3% |
| 21 | Thailand | USD 1.3 mn | 0.02% | USD 2.1 mn | 5.3% |
| 22 | Argentina | USD 0.63 mn | 0.01% | USD 2.1 mn | 12.9% |
| 23 | Chile | USD 0.63 mn | 0.01% | USD 1.1 mn | 5.3% |
| 24 | Czech Republic | USD 0.63 mn | 0.01% | USD 1.1 mn | 5.3% |
| 25 | Austria | USD 0.63 mn | 0.01% | USD 1.1 mn | 5.3% |
| Rest of world | USD 12 mn | 0.2% | USD 17 mn | 3.5% |
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
Competitive landscape
Group 1: Global leaders
- CVS Health
- Walgreens Boots Alliance
- Kroger
Group 2: Regional and specialist players
- Hy-Vee
- Clicks Group
- Dis-Chem
- Meijer
- Albertsons Companies
Research methodology
Every figure on this page comes from the research framework that we apply to all of the markets we cover. The 2025 base for the retail clinic market is built from the volume sold and the price that buyers pay, and is cross-checked against the size of the wider industry the market belongs to. Where a market can be sized in more than one way, the routes are compared before a figure is set.
The forecast runs year by year from the 2025 base to 2036. Growth in each year reflects demand from the industries that buy the product, adoption of new technology, pricing, regulation and replacement cycles. Volume and price are modelled together, so revenue in each year equals volume multiplied by average price. The 2026 to 2036 compound annual growth rate of 5.3% is calculated from the resulting values.
The market is divided by service, by operator type, by location, by payer, by staffing. The 25 largest countries are ranked by revenue earned from sales to buyers in each country, not by where the product is made. Segment values and country values add up to the market total in every year, and every report is checked for consistency before it is published.
Companies are placed in three groups: global leaders, regional and specialist players, and emerging and niche players. The groups describe how companies compete in the market. They are not a ranking and they are not market shares.
Our analysts also carry out primary research. Customized reports add interviews with key opinion leaders, such as senior executives, technical specialists and buyers, to test the assumptions behind the numbers for the question being asked.
Frequently asked questions
How big is the retail clinic market?
The global retail clinic market is estimated at USD 6.0 bn in 2025 and USD 6.3 bn in 2026.
How fast will the retail clinic market grow?
It is forecast to reach USD 10.6 bn by 2036, a compound annual growth rate of 5.3% from 2026, an increase of USD 4.3 bn.
Which country is the largest market for retail clinic?
United States is the largest market by revenue at USD 5.4 bn in 2026, 86.0% of the global total. The three largest countries together hold 93.0%.
Which country is growing fastest?
Among the ten largest markets, Brazil is growing fastest at 8.9% a year from 2026 to 2036.
Which retail clinic segment is largest?
In the by service split, Acute minor illness is the largest segment with 42.0% of 2026 revenue.
Who are the leading retail clinic companies?
Global leaders include CVS Health, Walgreens Boots Alliance, Kroger.
Need the full report?
Request a sample to see the structure, tables and country detail.
Request a free sampleRelated markets in Healthcare
- Good Manufacturing Practice ComplianceUSD 6.3 bn · 8.5% CAGR
- UltrafiltrationUSD 6.4 bn · 9.5% CAGR
- Fiber SupplementsUSD 6.4 bn · 6.5% CAGR
- Single Use BioreactorUSD 6.2 bn · 12.0% CAGR
- Artificial Pancreas DeviceUSD 6.2 bn · 12.5% CAGR
- Tissue EngineeringUSD 6.0 bn · 10.5% CAGR
- Liquid HandlingUSD 6.0 bn · 7.5% CAGR
- Cleanroom EquipmentUSD 6.0 bn · 8.0% CAGR